TY - JOUR AU - Mariette, X. AU - Seror, R. AU - Quartuccio, L. PY - 2015 DA - 2015// TI - Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study JO - Ann Rheum Dis. VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-203991 DO - 10.1136/annrheumdis-2013-203991 ID - Mariette2015 ER - TY - JOUR AU - Brkic, Z. AU - Versnel, M. A. PY - 2014 DA - 2014// TI - Type I IFN signature in primary Sjögren’s syndrome patients JO - Expert Rev Clin Immunol. VL - 10 UR - https://doi.org/10.1586/1744666X.2014.876364 DO - 10.1586/1744666X.2014.876364 ID - Brkic2014 ER - TY - JOUR AU - Mavragani, C. P. AU - Moutsopoulos, H. M. PY - 2014 DA - 2014// TI - Sjögren’s syndrome JO - Annu Rev Pathol Mech Dis. VL - 9 UR - https://doi.org/10.1146/annurev-pathol-012513-104728 DO - 10.1146/annurev-pathol-012513-104728 ID - Mavragani2014 ER - TY - JOUR AU - Devauchelle-Pensec, V. AU - Mariette, X. AU - Jousse-Joulin, S. PY - 2014 DA - 2014// TI - Treatment of primary Sjögren syndrome with rituximab: a randomized trial JO - Ann Intern Med. VL - 160 UR - https://doi.org/10.7326/M13-1085 DO - 10.7326/M13-1085 ID - Devauchelle-Pensec2014 ER - TY - JOUR AU - Guellec, D. AU - Cornec, D. AU - Jousse-Joulin, S. PY - 2013 DA - 2013// TI - Diagnostic value of labial minor salivary gland biopsy for Sjögren’s syndrome: a systematic review JO - Autoimmunity Reviews. VL - 12 UR - https://doi.org/10.1016/j.autrev.2012.08.001 DO - 10.1016/j.autrev.2012.08.001 ID - Guellec2013 ER - TY - JOUR AU - Zhou, D. AU - McNamara, N. A. PY - 2014 DA - 2014// TI - Macrophages: important players in primary Sjögren’s syndrome? JO - Expert Rev Clin Immunol. VL - 10 UR - https://doi.org/10.1586/1744666X.2014.900441 DO - 10.1586/1744666X.2014.900441 ID - Zhou2014 ER - TY - JOUR AU - Al-Tarawneh, S. K. AU - Border, M. B. AU - Dibble, C. F. PY - 2011 DA - 2011// TI - Defining salivary biomarkers using mass spectrometry-based proteomics: a systematic review JO - OMICS. VL - 15 UR - https://doi.org/10.1089/omi.2010.0134 DO - 10.1089/omi.2010.0134 ID - Al-Tarawneh2011 ER - TY - JOUR AU - Deutsch, O. AU - Krief, G. AU - Konttinen, Y. T. PY - 2015 DA - 2015// TI - Identification of Sjögren’s syndrome oral fluid biomarker candidates following high-abundance protein depletion JO - Rheumatology (Oxford) VL - 54 UR - https://doi.org/10.1093/rheumatology/keu405 DO - 10.1093/rheumatology/keu405 ID - Deutsch2015 ER - TY - JOUR AU - Fleissig, Y. AU - Deutsch, O. AU - Reichenberg, E. PY - 2009 DA - 2009// TI - Different proteomic protein patterns in saliva of Sjögren’s syndrome patients JO - Oral Dis. VL - 15 UR - https://doi.org/10.1111/j.1601-0825.2008.01465.x DO - 10.1111/j.1601-0825.2008.01465.x ID - Fleissig2009 ER - TY - JOUR AU - Giusti, L. AU - Baldini, C. AU - Bazzichi, L. PY - 2007 DA - 2007// TI - Proteomic diagnosis of Sjögren’s syndrome JO - Expert Rev Proteomics. VL - 4 UR - https://doi.org/10.1586/14789450.4.6.757 DO - 10.1586/14789450.4.6.757 ID - Giusti2007 ER - TY - JOUR AU - Hu, S. AU - Vissink, A. AU - Arellano, M. PY - 2011 DA - 2011// TI - Identification of autoantibody biomarkers for primary Sjögren’s syndrome using protein microarrays JO - Proteomics. VL - 11 UR - https://doi.org/10.1002/pmic.201000206 DO - 10.1002/pmic.201000206 ID - Hu2011 ER - TY - JOUR AU - Peluso, G. AU - Santis, M. AU - Inzitari, R. PY - 2007 DA - 2007// TI - Proteomic study of salivary peptides and proteins in patients with Sjögren’s syndrome before and after pilocarpine treatment JO - Arthritis Rheum. VL - 56 UR - https://doi.org/10.1002/art.22738 DO - 10.1002/art.22738 ID - Peluso2007 ER - TY - JOUR AU - Ryu, O. H. AU - Atkinson, J. C. AU - Hoehn, G. T. PY - 2006 DA - 2006// TI - Identification of parotid salivary biomarkers in Sjögren’s syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis JO - Rheumatology. VL - 45 UR - https://doi.org/10.1093/rheumatology/kei212 DO - 10.1093/rheumatology/kei212 ID - Ryu2006 ER - TY - JOUR AU - Baldini, C. AU - Giusti, L. AU - Ciregia, F. PY - 2011 DA - 2011// TI - Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren’s syndrome and other sicca syndromes JO - Arthritis Res Ther VL - 13 UR - https://doi.org/10.1186/ar3523 DO - 10.1186/ar3523 ID - Baldini2011 ER - TY - JOUR AU - Quartuccio, L. AU - Salvin, S. AU - Fabris, M. PY - 2013 DA - 2013// TI - BLyS upregulation in Sjögren’s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands JO - Rheumatology (Oxford) VL - 52 UR - https://doi.org/10.1093/rheumatology/kes180 DO - 10.1093/rheumatology/kes180 ID - Quartuccio2013 ER - TY - JOUR AU - Gottenberg, J. E. AU - Seror, R. AU - Miceli-Richardo, C. PY - 2013 DA - 2013// TI - Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease acitivity in primary Sjögren’s syndrome. data at enrollment in the prospective ASSESS cohort JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0059868 DO - 10.1371/journal.pone.0059868 ID - Gottenberg2013 ER - TY - JOUR AU - Maria, N. I. AU - Brkic, Z. AU - Waris, M. PY - 2014 DA - 2014// TI - MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren’s syndrome JO - Ann Rheum Dis. VL - 73 UR - https://doi.org/10.1136/annrheumdis-2012-202552 DO - 10.1136/annrheumdis-2012-202552 ID - Maria2014 ER - TY - JOUR AU - Seror, R. AU - Ravaud, P. AU - Bowman, S. PY - 2010 DA - 2010// TI - EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome JO - Ann Rheum Dis. VL - 69 UR - https://doi.org/10.1136/ard.2009.110619 DO - 10.1136/ard.2009.110619 ID - Seror2010 ER - TY - JOUR AU - Moerman, R. V. AU - Arends, S. AU - Meiners, P. M. PY - 2014 DA - 2014// TI - EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomized controlled trial JO - Ann Rheum Dis. VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203736 DO - 10.1136/annrheumdis-2013-203736 ID - Moerman2014 ER - TY - JOUR AU - Vitali, C. AU - Bombardieri, S. AU - Jonsson, R. PY - 2002 DA - 2002// TI - Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group JO - Ann Rheum Dis. VL - 6 UR - https://doi.org/10.1136/ard.61.6.554 DO - 10.1136/ard.61.6.554 ID - Vitali2002 ER - TY - JOUR AU - Shiboski, S. C. AU - Shiboski, C. H. AU - Criswell, L. PY - 2012 DA - 2012// TI - American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort JO - Arthritis Care Res. VL - 64 UR - https://doi.org/10.1002/acr.21591 DO - 10.1002/acr.21591 ID - Shiboski2012 ER - TY - JOUR AU - Tsuboi, H. AU - Hagiwara, S. AU - Asashima, H. PY - 2013 DA - 2013// TI - Validation of different sets of criteria for the diagnosis of Sjögren’s syndrome in Japanese patients JO - Mod Rheumatol. VL - 23 UR - https://doi.org/10.3109/s10165-012-0812-9 DO - 10.3109/s10165-012-0812-9 ID - Tsuboi2013 ER - TY - JOUR AU - Brito-Zerón, P. AU - Kostov, B. AU - Solans, R. PY - 2014 DA - 2014// TI - Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients JO - Ann Rheum Dis. VL - 0 ID - Brito-Zerón2014 ER - TY - JOUR AU - Rohloff, J. C. AU - Gelinas, A. D. AU - Jarvis, T. C. PY - 2014 DA - 2014// TI - Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents JO - Mol Ther Nucleic Acids. VL - 3 UR - https://doi.org/10.1038/mtna.2014.49 DO - 10.1038/mtna.2014.49 ID - Rohloff2014 ER - TY - JOUR AU - Gold, L. AU - Ayers, D. AU - Bertino, J. PY - 2010 DA - 2010// TI - Aptamer-based multiplexed proteomic technology for biomarker discovery JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0015004 DO - 10.1371/journal.pone.0015004 ID - Gold2010 ER - TY - JOUR AU - Webber, J. AU - Stone, T. C. AU - Katilius, E. PY - 2014 DA - 2014// TI - Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscanTM) platform JO - Mol Cell Proteomics. VL - 13 UR - https://doi.org/10.1074/mcp.M113.032136 DO - 10.1074/mcp.M113.032136 ID - Webber2014 ER - TY - JOUR AU - Yoshimoto, K. AU - Tanaka, M. AU - Kojima, M. PY - 2011 DA - 2011// TI - Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren’s syndrome JO - Arthritis Res Ther VL - 13 UR - https://doi.org/10.1186/ar3493 DO - 10.1186/ar3493 ID - Yoshimoto2011 ER - TY - JOUR AU - Tomlins, S. A. AU - Mehra, R. AU - Rhodes, D. R. PY - 2007 DA - 2007// TI - Integrative molecular concept modeling of prostate cancer progression JO - Nat Genet. VL - 39 UR - https://doi.org/10.1038/ng1935 DO - 10.1038/ng1935 ID - Tomlins2007 ER - TY - JOUR AU - Markeljevic, J. AU - Sarac, H. AU - Bozina, N. PY - 2015 DA - 2015// TI - Serotonin transporter gene polymorphisms: relation with platelet serotonin level in patients with primary Sjogren’s syndrome JO - J Neuroimmunol. VL - 282 UR - https://doi.org/10.1016/j.jneuroim.2015.04.002 DO - 10.1016/j.jneuroim.2015.04.002 ID - Markeljevic2015 ER - TY - JOUR AU - Sarac, H. AU - Markeljevic, J. AU - Erdeljic, V. PY - 2013 DA - 2013// TI - Signal hyperintensities on brain magnetic resonance imaging in patients with primary Sjögren’s syndrome and frequent episodic tension-type headache; relation to platelet serotonin level and disease activity JO - J Rheumatol. VL - 40 UR - https://doi.org/10.3899/jrheum.121132 DO - 10.3899/jrheum.121132 ID - Sarac2013 ER - TY - JOUR AU - Delaleu, N. AU - Mydel, P. AU - Kwee, I. PY - 2015 DA - 2015// TI - High fidelity between saliva proteomics and the salivary glands’ biological state defines biomarker-signatures for primary Sjögren’s syndrome JO - Arthritis Rheumatol. VL - 67 UR - https://doi.org/10.1002/art.39015 DO - 10.1002/art.39015 ID - Delaleu2015 ER - TY - JOUR AU - Campar, A. AU - Isenberg, D. A. PY - 2010 DA - 2010// TI - Primary Sjögren’s syndrome activity and damage indices comparison JO - Eur J Clin Invest. VL - 40 UR - https://doi.org/10.1111/j.1365-2362.2010.02303.x DO - 10.1111/j.1365-2362.2010.02303.x ID - Campar2010 ER - TY - STD TI - Nocturne G, Seror R, Fogel O, et al. CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjögren Syndrome. Arthritis Rheumatol. 2015. doi:10. 1002/art.393915. ID - ref33 ER - TY - JOUR AU - Manzo, A. AU - Vitolo, B. AU - Humby, F. PY - 2008 DA - 2008// TI - Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint JO - Arthritis Rheum. VL - 58 UR - https://doi.org/10.1002/art.23966 DO - 10.1002/art.23966 ID - Manzo2008 ER - TY - JOUR AU - Gunn, M. D. AU - Ngo, V. N. AU - Ansel, K. M. PY - 1998 DA - 1998// TI - A B-cell-homing chemokine made in lymphoid follicles activates Burkitt’s lymphoma receptor-1 JO - Nature. VL - 391 UR - https://doi.org/10.1038/35876 DO - 10.1038/35876 ID - Gunn1998 ER - TY - JOUR AU - Cyster, J. G. AU - Ansel, K. M. AU - Reif, K. PY - 2000 DA - 2000// TI - Follicular stromal cells and lymphocyte homing to follicles JO - Immunol Rev. VL - 176 UR - https://doi.org/10.1034/j.1600-065X.2000.00618.x DO - 10.1034/j.1600-065X.2000.00618.x ID - Cyster2000 ER - TY - JOUR AU - Kramer, J. M. AU - Klimatcheva, E. AU - Rothstein, T. L. PY - 2013 DA - 2013// TI - CXCL13 is elevated in Sjögren’s syndrome in mice and humans and is implicated in disease pathogenesis JO - J Leukoc Biol. VL - 94 UR - https://doi.org/10.1189/jlb.0113036 DO - 10.1189/jlb.0113036 ID - Kramer2013 ER - TY - JOUR AU - Barone, F. AU - Bombardieri, M. AU - Manzo, A. PY - 2005 DA - 2005// TI - Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren’s syndrome JO - Arthritis Rheum. VL - 52 UR - https://doi.org/10.1002/art.21062 DO - 10.1002/art.21062 ID - Barone2005 ER - TY - JOUR AU - Barone, F. AU - Bombardieri, M. AU - Rosado, M. M. PY - 2008 DA - 2008// TI - CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren’s syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization JO - J Immunol. VL - 180 UR - https://doi.org/10.4049/jimmunol.180.7.5130 DO - 10.4049/jimmunol.180.7.5130 ID - Barone2008 ER - TY - JOUR AU - Fraustman, D. L. AU - Davis, M. PY - 2013 DA - 2013// TI - TNF receptor 2 and disease: autoimmunity and regenerative medicine JO - Front Immunol. VL - 4 ID - Fraustman2013 ER - TY - STD TI - Patel M, Oni L, Midgley A, et al. Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. Lupus. 2016;0:1–5. doi:10.1177/0961203316631634. ID - ref41 ER - TY - JOUR AU - Horiuchi, T. AU - Mitoma, H. AU - Harashima, S. PY - 2010 DA - 2010// TI - Transmembrane TNF-a: structure, function and interaction with anti-TNF agents JO - Rheumatology. VL - 49 UR - https://doi.org/10.1093/rheumatology/keq031 DO - 10.1093/rheumatology/keq031 ID - Horiuchi2010 ER - TY - JOUR AU - Svenungsson, E. AU - Gunnarsson, I. AU - Fei, G. Z. PY - 2003 DA - 2003// TI - Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus JO - Arthritis Rheum. VL - 48 UR - https://doi.org/10.1002/art.11264 DO - 10.1002/art.11264 ID - Svenungsson2003 ER - TY - JOUR AU - Ferreira, G. A. AU - Teixeira, A. AU - Calderano, D. C. PY - 2016 DA - 2016// TI - Atorvastatin reduced soluble receptors of TNF-alpha in systemic lupus erythematosus JO - Clin Exp Rheumatol. VL - 34 ID - Ferreira2016 ER - TY - JOUR AU - Turan, B. AU - Pfister, K. AU - Diener, P. A. PY - 2008 DA - 2008// TI - Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet’s disease JO - Scand J Rheumatol. VL - 37 UR - https://doi.org/10.1080/03009740701747137 DO - 10.1080/03009740701747137 ID - Turan2008 ER - TY - JOUR AU - Koski, H. AU - Janin, A. AU - Humphreys-Beher, M. G. PY - 2001 DA - 2001// TI - Tumor necrosis factor-alpha and receptor for it in labial salivary glands in Sjögren’s syndrome JO - Clin Exp Rheumatol. VL - 19 ID - Koski2001 ER - TY - JOUR AU - Elishmereni, M. AU - Levi-Schaffer, F. PY - 2011 DA - 2011// TI - CD48: a co-stimulatory receptor of immunity JO - Int J Biochem Cell Biol. VL - 43 UR - https://doi.org/10.1016/j.biocel.2010.09.001 DO - 10.1016/j.biocel.2010.09.001 ID - Elishmereni2011 ER - TY - JOUR AU - Gangwar, R. A. PY - 2016 DA - 2016// TI - sCD48 is anti-inflammatory in S. aureus Enterotoxin B induced eosinophilic inflammation JO - Allergy ID - Gangwar2016 ER - TY - JOUR AU - Ariel, M. PY - 2006 DA - 2006// TI - CD48 is an allergen and IL-3-induced activation molecule on eosinophils JO - J Immunol. VL - 177 UR - https://doi.org/10.4049/jimmunol.177.1.77 DO - 10.4049/jimmunol.177.1.77 ID - Ariel2006 ER - TY - JOUR AU - Smith, G. M. PY - 1997 DA - 1997// TI - Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis JO - J Clinical Immunol. VL - 17 UR - https://doi.org/10.1023/A:1027327912204 DO - 10.1023/A:1027327912204 ID - Smith1997 ER - TY - JOUR AU - Boles, K. S. PY - 2001 DA - 2001// TI - 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes JO - Immunol Rev. VL - 181 UR - https://doi.org/10.1034/j.1600-065X.2001.1810120.x DO - 10.1034/j.1600-065X.2001.1810120.x ID - Boles2001 ER - TY - JOUR AU - Candon, S. AU - Gottenberg, J. E. AU - Bengoufa, D. PY - 2009 DA - 2009// TI - Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren’s syndrome: correlation with B-cell biomarkers and disease activity JO - Ann Rheum Dis. VL - 68 UR - https://doi.org/10.1136/ard.2008.095257 DO - 10.1136/ard.2008.095257 ID - Candon2009 ER - TY - JOUR AU - Mariette, X. AU - Roux, S. AU - Zhang, J. PY - 2003 DA - 2003// TI - The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome JO - Ann Rheum Dis. VL - 62 UR - https://doi.org/10.1136/ard.62.2.168 DO - 10.1136/ard.62.2.168 ID - Mariette2003 ER - TY - STD TI - Zhang J, Roschke V, Baker KP, et al. Cutting edge: a role for B lymphocytestimulator in systemic lupus erythematosus. J Immunol. 2001;166:6–10. ID - ref54 ER - TY - JOUR AU - Cheema, G. S. AU - Roschke, V. AU - Hilbert, D. M. PY - 2001 DA - 2001// TI - Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases JO - Arthritis Rheum. VL - 44 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Cheema2001 ER - TY - JOUR AU - Dai, S. AU - Jia, R. AU - Zhang, X. PY - 2014 DA - 2014// TI - The PD-1/PD-Ls pathway and autoimmune diseases JO - Cell Immunol. VL - 290 UR - https://doi.org/10.1016/j.cellimm.2014.05.006 DO - 10.1016/j.cellimm.2014.05.006 ID - Dai2014 ER - TY - JOUR AU - Messal, N. AU - Serriari, N. E. AU - Pastor, S. PY - 2011 DA - 2011// TI - PD-L2 is expressed on activated human T cells and regulates their function JO - Mol Immunol. VL - 48 UR - https://doi.org/10.1016/j.molimm.2011.06.436 DO - 10.1016/j.molimm.2011.06.436 ID - Messal2011 ER -